Your browser doesn't support javascript.
loading
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma.
Dieter, S M; Heining, C; Agaimy, A; Huebschmann, D; Bonekamp, D; Hutter, B; Ehrenberg, K R; Fröhlich, M; Schlesner, M; Scholl, C; Schlemmer, H-P; Wolf, S; Mavratzas, A; Jung, C S; Gröschel, S; von Kalle, C; Eils, R; Brors, B; Penzel, R; Kriegsmann, M; Reuss, D E; Schirmacher, P; Stenzinger, A; Federspil, P A; Weichert, W; Glimm, H; Fröhling, S.
Afiliação
  • Dieter SM; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Heining C; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Agaimy A; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Huebschmann D; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Bonekamp D; Section for Personalized Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Hutter B; Institute of Pathology, Erlangen University Hospital, Erlangen, Germany.
  • Ehrenberg KR; Division of Theoretical Bioinformatics, DKFZ, Heidelberg, Germany.
  • Fröhlich M; Department of Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, and BioQuant, Heidelberg University, Heidelberg, Germany.
  • Schlesner M; Department of Pediatric Immunology, Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Scholl C; Division of Radiology, DKFZ, Heidelberg, Germany.
  • Schlemmer HP; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Wolf S; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, Heidelberg, Germany.
  • Mavratzas A; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jung CS; Department of Medical Oncology, NCT Heidelberg, and Department of Internal Medicine VI, Heidelberg University Hospital, Heidelberg, Germany.
  • Gröschel S; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • von Kalle C; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, Heidelberg, Germany.
  • Eils R; Division of Theoretical Bioinformatics, DKFZ, Heidelberg, Germany.
  • Brors B; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Penzel R; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Kriegsmann M; Division of Radiology, DKFZ, Heidelberg, Germany.
  • Reuss DE; Genomics and Proteomics Core Facility, DKFZ, Heidelberg, Germany.
  • Schirmacher P; Department of Medical Oncology, NCT Heidelberg, and Department of Internal Medicine VI, Heidelberg University Hospital, Heidelberg, Germany.
  • Stenzinger A; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Federspil PA; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weichert W; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Glimm H; Section for Personalized Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Fröhling S; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ann Oncol ; 28(1): 142-148, 2017 01 01.
Article em En | MEDLINE | ID: mdl-27687311
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Seios Paranasais / Carcinoma / Proteínas Proto-Oncogênicas c-kit Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Seios Paranasais / Carcinoma / Proteínas Proto-Oncogênicas c-kit Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article